Navigation Links
Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
Date:1/28/2008

Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.

For additional information on Inverness Medical Innovations, please visit http://www.invernessmedical.com.

About Matria

Matria Healthcare is a leading provider of integrated comprehensive health enhancement programs to health plans, employers and government agencies. Matria is dedicated to developing better educated, motivated and self-enabled healthcare consumers and supporting clinicians in managing the care of their patients. Matria manages major chronic diseases and episodic conditions including diabetes, congestive heart failure, coronary artery disease, asthma, chronic obstructive pulmonary disease, high-risk obstetrics, cancer, musculoskeletal and chronic pain, depression, obesity, and other conditions. Matria delivers programs that address wellness, healthy living, productivity improvement and navigation of the healthcare system, and provides case management of acute and catastrophic conditions. Headquartered in Marietta, Georgia, Matria operates through nearly 50 offices around the United States.

For additional information on Matria please visit http://www.matria.com.

Additional Information About the Proposed Transaction and Where to Find it:

This press release is not a proxy statement or a prospectus for the proposed transaction. Inverness will file a registration statement on Form S-4 in connection with the proposed transaction, which will include Matria's proxy statement and Inverness's prospectus for the proposed transaction. INVESTORS ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS, WHICH WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION, IF AND WHEN IT BECOMES AVAILABLE. The prox
'/>"/>

SOURCE Inverness Medical Innovations
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Inverness Completes Acquisition of Cholestech
2. Inverness Medical Innovations Acquires Bio-Stat Healthcare Group
3. Inverness Medical Innovations Acquires Alere Medical
4. Inverness Medical Innovations Announces Closing of Public Offering
5. Inverness Medical Innovations to Participate at 2007 RBC Healthcare Conference on December 12, 2007
6. Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory
7. MSU engineering team designs innovative medical device
8. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
9. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
10. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
11. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013 Degenerative changes to the area of ... with compression, known as the nucleus pulposus, has been demonstrated ... new study led by researchers at the Icahn School of ... journal PLOS ONE, reinforces the importance of diabetes in inducing ... is the first study to demonstrate that these changes can ...
(Date:5/17/2013)... A May 13, 2013 report by CNN ... Getting Surgery” examines the typical motivation of post-divorce ... to the article these patients typically fit into three ... freshen their look because they’re now back on the ... plastic surgery before their divorce but never went ...
(Date:5/17/2013)... New York (PRWEB) May 17, 2013 ... dedicated to protecting the rights of victims injured by ... DePuy Orthopaedics Inc. has said in a May 16, ... some of its metal-on-metal and ceramic-on-metal hip replacement products; ... and the Complete Ceramic-on-Metal Acetabular Hip System will no ...
(Date:5/17/2013)... women in Texas who are found to have an ... one of their breasts end up having an old-fashioned ... is malignant. Since 2001, national expert panels have recommended ... breast lumps or masses should be minimally invasive biopsy. ... ultrasonographic or X-ray guidance, with either a fine needle ...
(Date:5/17/2013)... HealthDay Reporter , , FRIDAY, May 17 (HealthDay News) -- There ... a musical instrument and a GPS system, and now there,s ... you,re having a heart attack. The app, which was ... diagnose certain kinds of severe heart attacks, called STEMIs, before ... in the experimental stage, but it has undergone field testing. ...
Breaking Medicine News(10 mins):Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 2Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 3Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 4Health News:Plastic Surgery – Is ‘Revenge’ Cosmetic Surgery on the Rise? 2Health News:Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products 2Health News:Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products 3Health News:More than one-third of Texas women still receive unnecessary breast biopsy surgery 2Health News:Heart Attack? Doctors Soon May Have an App for That 2Health News:Heart Attack? Doctors Soon May Have an App for That 3
... about half of women age 65 and older would be ... rate for women falls to 12 percent. These facts ... in the latest installment of the Public Policy & Aging ... Society, the public policy branch of The Gerontological Society of ...
... Reporter , THURSDAY, Dec. 16 (HealthDay News) -- Federal ... drug Avastin to fight breast cancer, citing the medication,s ... serious side effects. But the recommendation, announced by ... news conference, will not immediately affect breast cancer patients, ...
... The American Heart Association has recognized UC Irvine Healthcare,s ... patients. The Get With The Guidelines Heart Failure ... achieved at least 85 percent compliance for one year with ... medical center,s compliance rate was 96 percent. The "Plus" designation ...
... December 16, 2010 The Elsevier Foundation has ... Innovative Libraries in Developing Countries program, committing over ... developing countries. The 2010 grant recipients were selected ... potential for impact in the developing world. The ...
... World Health Organization set a target for the influenza vaccination ... population and an increase to more than 75% by 2010. ... old German states. In the current issue of Deutsches ... 845󈞞) the working group around Annicka M. Reuss presents rates ...
... Reporter , THURSDAY, Dec. 16 (HealthDay News) -- Researchers ... -- the part of the brain believed to generate ... improve treatment for post-traumatic stress disorder (PTSD) and other ... confirming that the almond-shaped structure is crucial for triggering ...
Cached Medicine News:Health News:Brief clarifies Social Security's value for women 2Health News:FDA Advises Against Avastin as Treatment for Breast Cancer 2Health News:FDA Advises Against Avastin as Treatment for Breast Cancer 3Health News:UC Irvine Medical Center recognized for heart failure program 2Health News:Elsevier Foundation announces 2010 grants for libraries in developing countries 2Health News:Brain Anomaly Leaves Woman Without Fear 2Health News:Brain Anomaly Leaves Woman Without Fear 3
(Date:5/17/2013)... Ill. , May 17, 2013  Sony Biotechnology ... Sony SP6800 Spectral Analyzer (SP6800).  Sony will be exhibiting ... which will be held at the San ... Diego, California , from May 20 - 22.  ... second analytical system, incorporating commercial audio-visual technologies into new ...
(Date:5/17/2013)... 17, 2013 Research explores ... outcomes research also   to   be presented ... SHPG ), the global specialty biopharmaceutical company, announces that ... at the American Psychiatric Association (APA) 166th Annual Meeting ... The data being presented represent Shire,s ongoing commitment to ...
(Date:5/17/2013)... today announced that it will report its 2013 first quarter earnings on ... Ed Borkowski , CFO, will host an analyst and ... To participate in the conference call within the U.S. and ... conference call outside the U.S. and Canada , dial ... Participants should dial in 10 minutes prior to the start of the ...
Breaking Medicine Technology:Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10
... Call to discuss the company,s third quarter financial ... 11:00 a.m. EDT (8:00 a.m. PDT). SUNNYVALE, Calif., ... PCYC ) today announced that it has entered ... leading French independent pharmaceutical company. The alliance will ...
... TLR8 Agonist to Advance for Treatment of AllergySAN DIEGO ... biopharmaceutical company focused on the development of novel Toll-Like ... respiratory and inflammatory diseases, announced today that it has ... selective intranasal TLR8 agonist for the treatment of allergic ...
Cached Medicine Technology:Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier 2Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier 3Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier 4Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier 5VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: